We are live on
!
Find out more
SFM
Sphera Funds Management Portfolio holdings
AUM
$767M
1-Year Est. Return
119.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.45%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$359M
AUM Growth
–
Cap. Flow
+$266M
Cap. Flow
% of AUM
73.97%
Top 10 Holdings %
Top 10 Hldgs %
47.3%
Holding
96
New
96
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$28.5M |
| 2 |
Pfizer
PFE
|
+$21.5M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$16M |
| 4 |
Merck
MRK
|
+$13.4M |
| 5 |
SHPG
Shire pic
SHPG
|
+$8.54M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.35% |
| 2 | Miscellaneous | 39.76% |
| 3 | Consumer Discretionary | 4.33% |
| 4 | Technology | 3.68% |
| 5 | Industrials | 3.52% |
Similar funds
ISWM
ACP
NIM
ACM
CBT
SPIA
CNB
HI
Sphera Funds Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Sphera Funds Management, which disclosed 96 positions worth $359M. Its ten largest holdings account for 47% of the portfolio.
Its largest position is GSK: 440,000 shares worth $29.4M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, followed by Miscellaneous and Consumer Discretionary.
- Sphera Funds Management's largest Q4 2013 buy was GSK: 440,000 shares worth $29.4M.
- Sphera Funds Management's ten largest holdings make up 47% of its $359M portfolio in Q4 2013.
- Sphera Funds Management disclosed 96 positions in Q4 2013, its first 13F filing on record.
Based on Sphera Funds Management's 13F filing for Q4 2013, filed 13 Feb 2014.